ALEMBIC
Quarterly Results Analysis [Dec2023]
ALEMBIC Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹39 Cr | ₹32 Cr | ₹37 Cr | ₹37 Cr | ₹31 Cr | ₹37 Cr | ₹22 Cr | ₹18 Cr |
Expenses | ₹28 Cr | ₹22 Cr | ₹26 Cr | ₹24 Cr | ₹20 Cr | ₹26 Cr | ₹17 Cr | ₹15 Cr |
Operating Income | ₹12 Cr | ₹10 Cr | ₹11 Cr | ₹13 Cr | ₹10 Cr | ₹11 Cr | ₹5 Cr | ₹3 Cr |
Other Income | ₹2 Cr | ₹48 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹59 Cr | ₹1 Cr | ₹4 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr |
Profit Before Tax | ₹11 Cr | ₹56 Cr | ₹12 Cr | ₹3 Cr | ₹11 Cr | ₹68 Cr | ₹4 Cr | ₹6 Cr |
Profit After Tax | ₹10 Cr | ₹52 Cr | ₹10 Cr | ₹5 Cr | ₹11 Cr | ₹61 Cr | ₹4 Cr | ₹5 Cr |
EPS | ₹2.39 | ₹3.53 | ₹1.73 | ₹1.88 | ₹1.78 | ₹4.49 | ₹-0.72 | ₹0.04 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALEMBIC | 2.5% | 16.4% | 58.3% |
SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -2.8% | 50.3% |
CIPLA | 4.5% | -3.1% | 52.8% |
DR REDDYS LABORATORIES | 4.6% | 1.4% | 22.2% |
ZYDUS LIFESCIENCES | 3.1% | -4.1% | 80.4% |
DIVIS LABORATORIES | 4.7% | 10.8% | 18.1% |
MANKIND PHARMA | 2.7% | 12.4% | NA |
TORRENT PHARMACEUTICALS | 6.1% | 5.3% | 66.2% |
LUPIN | 3.1% | -1.1% | 127.4% |
ALEMBIC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 21.81 % |
Y-o-Y | 28.45 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹39 Cr | 21.81 | |
Sep2023 | ₹32 Cr | -12.38 | |
Jun2023 | ₹37 Cr | -0.75 | |
Mar2023 | ₹37 Cr | 21.27 | |
Dec2022 | ₹31 Cr | -18.20 | |
Sep2022 | ₹37 Cr | 69.40 | |
Jun2022 | ₹22 Cr | 21.11 | |
Mar2022 | ₹18 Cr | - |
ALEMBIC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 15.07 % |
Y-o-Y | 11.88 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹12 Cr | 15.07 | |
Sep2023 | ₹10 Cr | -6.62 | |
Jun2023 | ₹11 Cr | -19.18 | |
Mar2023 | ₹13 Cr | 28.83 | |
Dec2022 | ₹10 Cr | -5.52 | |
Sep2022 | ₹11 Cr | 103.87 | |
Jun2022 | ₹5 Cr | 85.62 | |
Mar2022 | ₹3 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -5.53 % |
Y-o-Y | -12.93 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 29.7% | -5.53 | |
Sep2023 | 31.44% | 6.54 | |
Jun2023 | 29.51% | -18.55 | |
Mar2023 | 36.23% | 6.22 | |
Dec2022 | 34.11% | 15.51 | |
Sep2022 | 29.53% | 20.33 | |
Jun2022 | 24.54% | 53.28 | |
Mar2022 | 16.01% | - |
ALEMBIC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -80.82 % |
Y-o-Y | -8.32 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹10 Cr | -80.82 | |
Sep2023 | ₹52 Cr | 419.18 | |
Jun2023 | ₹10 Cr | 111.91 | |
Mar2023 | ₹5 Cr | -56.56 | |
Dec2022 | ₹11 Cr | -82.33 | |
Sep2022 | ₹61 Cr | 1,486.79 | |
Jun2022 | ₹4 Cr | -16.99 | |
Mar2022 | ₹5 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -84.25 % |
Y-o-Y | -28.63 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 25.23 % | -84.25 | |
Sep2023 | 160.19 % | 492.42 | |
Jun2023 | 27.04 % | 113.59 | |
Mar2023 | 12.66 % | -64.19 | |
Dec2022 | 35.35 % | -78.40 | |
Sep2022 | 163.68 % | 836.92 | |
Jun2022 | 17.47 % | -31.46 | |
Mar2022 | 25.49 % | - |
ALEMBIC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -32.29 % |
Y-o-Y | 34.27 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹2.39 | -32.29 | |
Sep2023 | ₹3.53 | 104.05 | |
Jun2023 | ₹1.73 | -7.98 | |
Mar2023 | ₹1.88 | 5.62 | |
Dec2022 | ₹1.78 | -60.36 | |
Sep2022 | ₹4.49 | Positive | |
Jun2022 | ₹-0.72 | Negative | |
Mar2022 | ₹0.04 | - |
You may also like the below Video Courses